LIPO
Lipella Pharmaceuticals
LIPO
LIPO
Delisted
LIPO was delisted on the 18th of June, 2025.
4 hedge funds and large institutions have $59.5K invested in Lipella Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$7.38K |
| 2 |
2
Wells Fargo
San Francisco,
California
|
$42 |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$258 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $51.8K | 34,520 | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $7.38K | 4,920 | +3,314 | +206% |
|
|
3
UBS Group
Zurich,
Switzerland
| $258 | 172 | -2,249 | -93% |
|
|
4
Wells Fargo
San Francisco,
California
| $42 | 28 | +19 | +211% |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|